The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) that was announced yesterday points toward a new path for CRISPR gene editing te
Lensabl, the company that has built a business putting prescription lenses into any style of glasses frame, has raised $3.7 million in a new round of funding. Lensabl makes it easy to put new lenses
Johnson & Johnson, of BAND-AID and Tylenol (and about half the inventory at your local drugstore) fame, is teaming up with Shenzhen-based accelerator and hardware investor HAX to put some weight b
Google and Johnson & Johnson have announced that the will team up to develop an advanced, robot-assisted surgery platform. The team effort will involve “capabilities, intellectual property a